Multiple Sclerosis Patients' Benefit-Risk Preferences: Serious Adverse Event Risk versus Treatment Efficacy
Citation
Johnson, F., Van Houtven, G., Ozdemir, S., Hass, S., White, J., Francis, G., ... Phillips, T. (2009). Multiple Sclerosis Patients' Benefit-Risk Preferences: Serious Adverse Event Risk versus Treatment Efficacy. Journal of Neurology, 256, 554 - 562.